New aspects in the pathophysiology of dyskinesia. Salpêtrière Deep Brain Stimulation Group.
Damier
P
P
Centre d'investigation clinique-Fédération de Neurologie, Groupe hospitalier Pitié-Salpêtrière, Paris, France.
D000818:Animals; D000978:Antiparkinson Agents / Q000009:adverse effects; D001921:Brain / Q000503:physiopathology; D018450:Disease Progression; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D004558:Electric Stimulation; D006801:Humans; D007980:Levodopa / Q000009:adverse effects; D009462:Neurology / Q000639:trends*; D010300:Parkinson Disease / Q000188:drug therapy
D000978:Antiparkinson Agents; D007980:Levodopa